Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kojiro Tashiro

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Journal of Clinical Medicine|August 27, 2021
The Impact of ABO Blood Type on Developing Venous Thromboembolism in Cancer Patients: Systematic Review and Meta-AnalysisFumihiko Urabe, Shoji Kimura, Kosuke Iwatani, et al.
International Journal of Clinical Oncology|June 4, 2020
Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancerWataru Fukuokaya, Takahiro Kimura, Fumihiko Urabe, et al.
IJU Case Reports|November 6, 2023
Novel technique for cognitive magnetic resonance imaging-transperineal ultrasound fusion transperineal prostate biopsy with injection of bubbled jelly into urethra after abdominoperineal excisionKeiichiro Miyajima, Fumihiko Urabe, Juria Nakano, et al.
Japanese Journal of Clinical Oncology|January 24, 2026
Triplet therapy versus androgen receptor pathway inhibitor-doublet therapy in metastatic castration-sensitive prostate cancer: a real-world multicenter retrospective comparisonFumihiko Urabe, Takafumi Yanagisawa, Wataru Fukuokaya, et al.
Japanese Journal of Clinical Oncology|January 14, 2026
Prognostic impact of intraductal carcinoma of the prostate and PTEN loss in metastatic castration-sensitive prostate cancer treated with androgen receptor pathway inhibitorsShun Sato, Fumihiko Urabe, Yuya Iwamoto, et al.
Andrology|September 12, 2021
Differences in sex hormone recovery profile after cessation of 12-week gonadotropin-releasing hormone antagonist versus agonist therapyHiroshi Sasaki, Kenta Miki, Kojiro Tashiro, et al.
International Journal of Clinical Oncology|October 2, 2021
How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?Fumihiko Urabe, Takahiro Kimura, Hiroshi Sasaki, et al.
Medical Molecular Morphology|January 15, 2020
The expression of MYC is strongly dependent on the circular PVT1 expression in pure Gleason pattern 4 of prostatic cancerMiyaka Umemori, Morito Kurata, Akiko Yamamoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 9, 2014
[A case of percutaneous BCG perfusion therapy for CIS of upper urinary tract CIS after radical cystectomy with ileal neobladder]Koki Obayashi, Jun Miki, Kanako Kasai, et al.
Journal of Clinical Medicine|October 13, 2021
Risk Factors for Perioperative Hemodynamic Instability in Pheochromocytoma: A Systematic Review and Meta-AnalysisFumihiko Urabe, Shoji Kimura, Kosuke Iwatani, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Journal of Clinical Medicine|August 27, 2021
The Impact of ABO Blood Type on Developing Venous Thromboembolism in Cancer Patients: Systematic Review and Meta-AnalysisFumihiko Urabe, Shoji Kimura, Kosuke Iwatani, et al.
International Journal of Clinical Oncology|June 4, 2020
Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancerWataru Fukuokaya, Takahiro Kimura, Fumihiko Urabe, et al.
IJU Case Reports|November 6, 2023
Novel technique for cognitive magnetic resonance imaging-transperineal ultrasound fusion transperineal prostate biopsy with injection of bubbled jelly into urethra after abdominoperineal excisionKeiichiro Miyajima, Fumihiko Urabe, Juria Nakano, et al.
Japanese Journal of Clinical Oncology|January 24, 2026
Triplet therapy versus androgen receptor pathway inhibitor-doublet therapy in metastatic castration-sensitive prostate cancer: a real-world multicenter retrospective comparisonFumihiko Urabe, Takafumi Yanagisawa, Wataru Fukuokaya, et al.
Japanese Journal of Clinical Oncology|January 14, 2026
Prognostic impact of intraductal carcinoma of the prostate and PTEN loss in metastatic castration-sensitive prostate cancer treated with androgen receptor pathway inhibitorsShun Sato, Fumihiko Urabe, Yuya Iwamoto, et al.
Andrology|September 12, 2021
Differences in sex hormone recovery profile after cessation of 12-week gonadotropin-releasing hormone antagonist versus agonist therapyHiroshi Sasaki, Kenta Miki, Kojiro Tashiro, et al.
International Journal of Clinical Oncology|October 2, 2021
How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?Fumihiko Urabe, Takahiro Kimura, Hiroshi Sasaki, et al.
Medical Molecular Morphology|January 15, 2020
The expression of MYC is strongly dependent on the circular PVT1 expression in pure Gleason pattern 4 of prostatic cancerMiyaka Umemori, Morito Kurata, Akiko Yamamoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 9, 2014
[A case of percutaneous BCG perfusion therapy for CIS of upper urinary tract CIS after radical cystectomy with ileal neobladder]Koki Obayashi, Jun Miki, Kanako Kasai, et al.
Journal of Clinical Medicine|October 13, 2021
Risk Factors for Perioperative Hemodynamic Instability in Pheochromocytoma: A Systematic Review and Meta-AnalysisFumihiko Urabe, Shoji Kimura, Kosuke Iwatani, et al.
Pageof 10